These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2355131)

  • 1. Conservative approach to the treatment of chemotherapy-induced extravasation.
    Tsavaris NB; Karagiaouris P; Tzannou I; Komitsopoulou P; Bacoyiannis C; Karabellis A; Papanicolaou V; Mylonakis N; Karvounis N; Zoannou A
    J Dermatol Surg Oncol; 1990 Jun; 16(6):519-22. PubMed ID: 2355131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach.
    Tsavaris NB; Komitsopoulou P; Karagiaouris P; Loukatou P; Tzannou I; Mylonakis N; Kosmidis P
    Cancer Chemother Pharmacol; 1992; 30(4):330-3. PubMed ID: 1643703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical management after doxorubicin and epirubicin extravasation.
    Heitmann C; Durmus C; Ingianni G
    J Hand Surg Br; 1998 Oct; 23(5):666-8. PubMed ID: 9821616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dealing with chemotherapy extravasations: a new technique.
    Villalobos A
    J Am Anim Hosp Assoc; 2006; 42(4):321-5. PubMed ID: 16822773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study.
    Bertelli G; Gozza A; Forno GB; Vidili MG; Silvestro S; Venturini M; Del Mastro L; Garrone O; Rosso R; Dini D
    J Clin Oncol; 1995 Nov; 13(11):2851-5. PubMed ID: 7595748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Extravasation of cytostatic agents: a serious complication of oncological treatment].
    Alfaro-Rubio A; Sanmartín O; Requena C; Llombart B; Botella-Estrada R; Nagore E; Serra-Guillén C; Hueso L; Guillén C
    Actas Dermosifiliogr; 2006 Apr; 97(3):169-76. PubMed ID: 16796963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the appropriate management of tissue extravasation by antitumor agents?
    Larson DL
    Plast Reconstr Surg; 1985 Mar; 75(3):397-405. PubMed ID: 3883378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue distribution of epirubicin after severe extravasation in humans.
    Nedomansky J; Haslik W; Pluschnig U; Kornauth C; Deutschmann C; Hacker S; Steger GG; Bartsch R; Mader RM
    Cancer Chemother Pharmacol; 2021 Aug; 88(2):203-209. PubMed ID: 33907881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of mitoxantrone extravasation.
    Chang A
    J Oncol Pharm Pract; 2020 Jul; 26(5):1270-1273. PubMed ID: 31902285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor agents: extravasation, management, and surgical treatment.
    Scuderi N; Onesti MG
    Ann Plast Surg; 1994 Jan; 32(1):39-44. PubMed ID: 8141535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extravasation in intravenous chemotherapy].
    Harwood K; Herrmann R
    Dtsch Med Wochenschr; 1994 Mar; 119(10):359-60. PubMed ID: 8125043
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of extravasation necroses as a complication following intravenous cytostatic drug therapy. Results of an open pilot study].
    Kolarić K; Zupanc D; Stahl KW; Hinz J; Kempf SR; Ivankovic S
    Onkologie; 1988 Oct; 11(5):238-40. PubMed ID: 3059251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone-induced extravasation.
    Luke E
    Oncol Nurs Forum; 2005 Jan; 32(1):27-9. PubMed ID: 15682531
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluorescence microscopic demonstration and demarcation of doxorubicin extravasation. Experimental and clinical studies.
    Dahlstrøm KK; Chenoufi HL; Daugaard S
    Cancer; 1990 Apr; 65(8):1722-6. PubMed ID: 2317755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options in extravasation injury: an experimental study in rats.
    Yilmaz M; Demirdover C; Mola F
    Plast Reconstr Surg; 2002 Jun; 109(7):2418-23. PubMed ID: 12045569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Port-a-Cath extravasation of vesicant cytotoxics: surgical options for a rare complication of cancer chemotherapy.
    Haslik W; Hacker S; Felberbauer FX; Thallinger C; Bartsch R; Kornauth C; Deutschmann C; Mader RM
    Eur J Surg Oncol; 2015 Mar; 41(3):378-85. PubMed ID: 25515823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The significance of extravasation in oncological care].
    Zatkóné Puskás G
    Magy Onkol; 2008 Mar; 52(1):75-80. PubMed ID: 18403301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extravasation of systemic hemato-oncological therapies.
    Ener RA; Meglathery SB; Styler M
    Ann Oncol; 2004 Jun; 15(6):858-62. PubMed ID: 15151940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of cutaneous doxorubicin extravasation by rhodamine-filtered fluorescence microscopy.
    Duray PH; Cuono CB; Madri JA
    J Surg Oncol; 1986 Jan; 31(1):21-5. PubMed ID: 3945073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extravasation of chemotherapeutic agents: prevention and treatment.
    Goolsby TV; Lombardo FA
    Semin Oncol; 2006 Feb; 33(1):139-43. PubMed ID: 16473651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.